Literature DB >> 29904889

Clinical Presentation and Management of Headache in Pituitary Tumors.

Himanshu Suri1, Carrie Dougherty2.   

Abstract

PURPOSE OF REVIEW: This article provides an overview of headache in the setting of pituitary adenoma. The purpose of this article is to educate providers on the association, possible pathophysiology, and the clinical presentation of headache in pituitary tumor. RECENT
FINDINGS: Recent prospective evaluations indicate that risk factors for development of headache in the setting of pituitary adenoma include highly proliferative tumors, cavernous sinus invasion, and personal or family history of headache. Migraine-like headaches are the predominant presentation. Unilateral headaches are often ipsilateral to the side of cavernous sinus invasion. In summary, this paper describes how the size and type of pituitary tumors play an important role in causation of headaches. Pituitary adenoma-associated headache can also mimic primary headache disorders making recognition of a secondary process difficult. Therefore, this paper highlights the association of between trigeminal autonomic cephalgias and pituitary adenomas and urges practitioners to maintain a high index of suspicion when evaluating patients with these uncommon headache presentations. However, on balance, given the prevalence of both primary headache disorders and pituitary adenomas, determining causality can be challenging. A thoughtful and multidisciplinary approach is often the best management strategy, and treatment may require the expertise of multiple specialties including neurology, neurosurgery, and endocrinology.

Entities:  

Keywords:  Headache; Non-functioning pituitary adenomal; Pituitary adenomas; Prolactinoma; Trigeminal autonomic cephalgias

Mesh:

Year:  2018        PMID: 29904889     DOI: 10.1007/s11916-018-0710-8

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  56 in total

1.  Cluster-tic syndrome resolved by removal of pituitary adenoma: the first case.

Authors:  M Leone; M Curone; E Mea; G Bussone
Journal:  Cephalalgia       Date:  2004-12       Impact factor: 6.292

Review 2.  Postoperative hyperalgesia: its clinical importance and relevance.

Authors:  Oliver H G Wilder-Smith; Lars Arendt-Nielsen
Journal:  Anesthesiology       Date:  2006-03       Impact factor: 7.892

3.  No relationship between vasoactive intestinal polypeptide expression and headache in pituitary tumours.

Authors:  S Nathoo; J D Classey; M J Levy; K Meeran; M Powell; P J Goadsby
Journal:  Acta Neurol Scand       Date:  2005-05       Impact factor: 3.209

Review 4.  Incidental Findings and Normal Anatomical Variants on MRI of the Brain in Adults for Primary Headaches.

Authors:  Randolph W Evans
Journal:  Headache       Date:  2017-03-13       Impact factor: 5.887

5.  Prolactinoma-associated headache and dopamine agonist treatment.

Authors:  Mia-Maiken Kallestrup; Helge Kasch; Toke Østerby; Edith Nielsen; Troels S Jensen; Jens Ol Jørgensen
Journal:  Cephalalgia       Date:  2013-12-18       Impact factor: 6.292

6.  Headache in patients with pituitary adenoma: clinical and paraclinical findings.

Authors:  Christoph J Schankin; Anna K Reifferscheid; Markus Krumbholz; Jennifer Linn; Walter Rachinger; Sigrid Langer; Petra Sostak; Thomas Arzberger; Hans Kretzschmar; Andreas Straube
Journal:  Cephalalgia       Date:  2012-10-11       Impact factor: 6.292

7.  Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis.

Authors:  Annamaria Colao; Giovanni Vitale; Paolo Cappabianca; Francesco Briganti; Antonio Ciccarelli; Michele De Rosa; Stefano Zarrilli; Gaetano Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

8.  Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).

Authors:  Alberto Fernandez; Niki Karavitaki; John A H Wass
Journal:  Clin Endocrinol (Oxf)       Date:  2009-07-24       Impact factor: 3.478

9.  Cavernous sinus syndrome due to prolactinoma: resolution with bromocriptine.

Authors:  L W King; M E Molitch; J W Gittinger; S M Wolpert; J Stern
Journal:  Surg Neurol       Date:  1983-03

10.  Bilateral SUNCT-like headache in a patient with prolactinoma responsive to lamotrigine.

Authors:  Jasna Zidverc-Trajkovic; Svetlana Vujovic; Ana Sundic; Aleksandra Radojicic; Nadezda Sternic
Journal:  J Headache Pain       Date:  2009-09-11       Impact factor: 7.277

View more
  2 in total

1.  Endoscopic, Endonasal Transsphenoidal Surgery for Tumors of the Sellar and Suprasellar Region: A Monocentric Historical Cohort Study of 369 Patients.

Authors:  Laura Van Gerven; Zhen Qian; Anastasiya Starovoyt; Mark Jorissen; Jeroen Meulemans; Johannes van Loon; Steven De Vleeschouwer; Julie Lambert; Marie Bex; Vincent Vander Poorten
Journal:  Front Oncol       Date:  2021-05-07       Impact factor: 6.244

2.  Evaluation of the expression of necroptosis pathway mediators and its association with tumor characteristics in functional and non-functional pituitary adenomas.

Authors:  Mohammad E Khamseh; Alireza Sheikhi; Zahra Shahsavari; Mohammad Ghorbani; Hamideh Akbari; Mehrnaz Imani; Mahshid Panahi; Alimohammad Alimohammadi; Maryam Ameri; Shima Nazem; Vahid Salimi; Masoumeh Tavakoli-Yaraki
Journal:  BMC Endocr Disord       Date:  2022-01-04       Impact factor: 2.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.